Blocking thyroid hormone receptor offers new approach to prostate cancer treatment

An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid hormone plays a key role in the development and progression of prostate cancer. By blocking a specific thyroid hormone receptor, cancer growth was inhibited in both animal models and tumor cell cultures.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup